Core C: Community Outreach and Translation Core
Core C: Community Outreach and Translation Core
批准号:
8322586
负责人:
David Albert Schwartz
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2014-07-31
关键词:
Air PollutionAllergensAsthmaChildChild health careColoradoCommunitiesCommunity OutreachDiseaseEndotoxinsEnvironmentEnvironmental ExposureEnvironmental HealthGoalsModelingPoliciesRegulationResearchResearch InfrastructureResearch PersonnelRuralRural CommunityThinkingTranslationsVirus DiseasesWorkcommunity based participatory researchknowledge translationmemberprogramsrespiratoryresponseuptake
中文摘要
我们儿童环境健康中心(CEHC)应用的总体目标是评估影响
环境暴露,特别是空气污染和内毒素对病毒感染的反应以及
儿童的过敏原暴露。社区外联和翻译核心(COTC)将作为一个论坛
交流关于环境对呼吸的影响的想法、想法和信息
科罗拉多州城市和农村儿童的健康。COTC将成为科学研究人员之间的桥梁
和社区利益相关者组织翻译和理解的方法和战略
社区成员。COTC将吸收现有的研究证据,同时通知CEHC
研究人员的研究需要对社会做出回应。最初我们在开发方面的工作
该模式将以丹佛的哮喘为中心,选择农村社区,然后扩展到其他呼吸系统
疾病,以及科罗拉多州的其他社区。
我们的具体目标包括:
1.建立一个由社区咨询委员会(CAB)提供信息的强大的COTC,并
通过遵循以社区为基础的参与性研究的原则完成其工作,
社区参与、知识转化和传播。
2.为回应社会的需要,协调中心将透过协调委员会编制现有的
与影响科罗拉多州儿童呼吸健康的因素有关的研究证据将是
用于为社区利益相关者的工作提供信息,如政策、法规和计划。
3.CAB将协助对CEHC研究的解释和关键信息,以及
为社区传播和吸收战略提供信息。
4.利用现有的社区基础设施和伙伴关系,允许试行翻译
和实施战略,以确定最有效的战略,从而实现
在社区中进行研究。
英文摘要
The overall goal of our Children's Environmental Health Center (CEHC) application is to evaluate the impact
of environmental exposures, specifically air pollution and endotoxin, on response to viral infection and
allergen exposure in children. The Community Outreach and Translation Core (COTC) will serve as a forum
for exchanging ideas, thoughts and information regarding the impact of the environment on the respiratory
health of children in urban and rural Colorado. The COTC will be a bridge between scientific investigators
and community stakeholders for organizing approaches and strategies for translation and uptake by
community members. The COTC will assimilate the available research evidence while informing the CEHC
research investigators of the need for responsive research to the community. Initially our work in developing
this model will center on asthma in Denver and select rural communities and then extend to other respiratory
illnesses, and other communities in Colorado.
Our specific aims include the following:
1. To develop a strong COTC that is informed by the Community Advisory Board (CAB) and
accomplishes its work through following the principles of community based participatory research,
community engagement and knowledge translation and disseminafion.
2. To be responsive to the needs of the community, the CEHC through the COTC will compile existing
research evidence related to factors that impact respiratory health of children in Colorado that will be
used to inform the work of community stakeholders, such as policies, regulations, and programs.
3. The CAB will assist with the interpretafion and key messaging of the CEHCs research as well as
informing the strategies for community dissemination and uptake.
4. To leverage existing community infrastructures and partnerships to permit the piloting of translation
and implementation strategies that will identify the most effective strategies resulting in the uptake of
research in communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms Regulating Lung Injury and Early Lung Fibrosis
-
批准号:10627593
-
项目类别:
-
资助金额:$245.07万
-
财政年份:2023
-
负责人:David Albert Schwartz
-
依托单位:
Administrative Core
-
批准号:10627594
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2023
-
负责人:David Albert Schwartz
-
依托单位:
Endoplasmic reticulum stress in MUC5B-driven lung fibrosis
-
批准号:10627599
-
项目类别:
-
资助金额:$64.06万
-
财政年份:2023
-
负责人:David Albert Schwartz
-
依托单位:
Molecular Determinants of Usual Interstitial Pneumonia (UIP)
-
批准号:10440715
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2022
-
负责人:David Albert Schwartz
-
依托单位:
Molecular Determinants of Usual Interstitial Pneumonia (UIP)
-
批准号:10594554
-
项目类别:
-
资助金额:$71.02万
-
财政年份:2022
-
负责人:David Albert Schwartz
-
依托单位:
lncRNAs, Linking Genetic Susceptibility to Molecular Phenotype in IPF
-
批准号:10513288
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:David Albert Schwartz
-
依托单位:
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
-
批准号:10514944
-
项目类别:
-
资助金额:$122.57万
-
财政年份:2020
-
负责人:David Albert Schwartz
-
依托单位:
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
-
批准号:10219354
-
项目类别:
-
资助金额:$94.44万
-
财政年份:2020
-
负责人:David Albert Schwartz
-
依托单位:
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
-
批准号:10683293
-
项目类别:
-
资助金额:$121.92万
-
财政年份:2020
-
负责人:David Albert Schwartz
-
依托单位:
Functional Genetics in Idiopathic Pulmonary Fibrosis
-
批准号:8754053
-
项目类别:
-
资助金额:$21.33万
-
财政年份:2014
-
负责人:David Albert Schwartz
-
依托单位:
MUC5B, a novel therapeutic target for Idiopathic Pulmonary Fibrosis (IPF)
-
批准号:9321207
-
项目类别:
-
资助金额:$157.74万
-
财政年份:2014
-
负责人:David Albert Schwartz
-
依托单位:
MUC5B, a novel therapeutic target for Idiopathic Pulmonary Fibrosis (IPF)
-
批准号:8750344
-
项目类别:
-
资助金额:$152.26万
-
财政年份:2014
-
负责人:David Albert Schwartz
-
依托单位:
Functional Genetics in Idiopathic Pulmonary Fibrosis
-
批准号:9085537
-
项目类别:
-
资助金额:$52.37万
-
财政年份:2014
-
负责人:David Albert Schwartz
-
依托单位:
Core C: Community Outreach and Translation Core
-
批准号:8529264
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2013
-
负责人:David Albert Schwartz
-
依托单位:
Genetic and Epigenetic Changes in MUC5B and Fibrosing Interstitial Lung Disease
-
批准号:8331033
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:David Albert Schwartz
-
依托单位:
Genetic and Epigenetic Changes in MUC5B and Fibrosing Interstitial Lung Disease
-
批准号:8965972
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:David Albert Schwartz
-
依托单位:
Genetic and Epigenetic Changes in MUC5B and Fibrosing Interstitial Lung Disease
-
批准号:8597931
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:David Albert Schwartz
-
依托单位:
Genetic and Epigenetic Changes in MUC5B and Fibrosing Interstitial Lung Disease
-
批准号:8764698
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:David Albert Schwartz
-
依托单位:
Supercomputer Linux Cluster for Genomics and Proteomics
-
批准号:8051874
-
项目类别:
-
资助金额:$59.69万
-
财政年份:2011
-
负责人:David Albert Schwartz
-
依托单位:
GWAS in Fibrosing Interstitial Lung Disease
-
批准号:8119630
-
项目类别:
-
资助金额:$164.22万
-
财政年份:2011
-
负责人:David Albert Schwartz
-
依托单位:
海外基金